Competa, Radzmer .

HRN: 27-70-42  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2025
CEFUROXIME 1.5GM (VIAL)
08/28/2025
09/04/2025
IV
650 Mg
Q8h
T/c Intussusception
Checking Initial Appropriateness 
08/28/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/28/2025
09/04/2025
IV
200 Mg
Q 8h
T/c Intussusception
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: